|
Slutkurs
Andra börsplatser
|
5-dagars förändring | Förändring 1 jan. | ||
| 37,40 USD | -.--% |
|
+1,63 % | +23,84 % |
| 06-29 | Gedeon Richter meddelar att styrelseledamoten Peter Cserhati avgår med verkan från den 1 juli 2026 | CI |
| 06-16 | AI i Ungern kan frigöra produktivitetsvinster på 15 miljarder euro enligt McKinsey | RE |
Försäljning 2025 per affärssegment
Försäljning 2025 efter Geografi
Historisk fördelning av intäkter per affärssegment
Operating Income: Fördelning efter verksamhetssegment
| Skatteperiod: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals - Women's Healthcare (WHC) | - | - | 256 md | 286 md | 329 md | |||||
Gross Profit | - | - | 169 md | 193 md | 219 md | |||||
Operating Income | - | - | 39,43 md | 44,34 md | 53,06 md | |||||
Pharmaceuticals - Neuropsychiatry (CNS) | - | - | 206 md | 243 md | 265 md | |||||
Gross Profit | - | - | 204 md | 241 md | 263 md | |||||
Operating Income | - | - | 175 md | 215 md | 231 md | |||||
Pharmaceuticals - General Medicines (GM) | - | - | 227 md | 251 md | 250 md | |||||
Gross Profit | - | - | 122 md | 130 md | 129 md | |||||
Operating Income | - | - | 43,32 md | 39,97 md | 37,02 md | |||||
Pharmaceuticals - Pharma Other | - | - | 13,02 md | 11,12 md | 6,99 md | |||||
Gross Profit | - | - | 1,73 md | 291 mn | −1,71 md | |||||
Operating Income | - | - | −616 mn | −1,68 md | −3,18 md | |||||
Pharmaceuticals | 505 md | 656 md | - | - | - | |||||
Total Assets | 1 220 md | 1 412 md | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
CAPEX | −142 md | −71,16 md | - | - | - | |||||
Gross Profit | 338 md | 447 md | - | - | - | |||||
D&A | 43,44 md | 46,97 md | - | - | - | |||||
Operating Income | 135 md | 152 md | - | - | - | |||||
Biological Products | ||||||||||
Pharmaceuticals - Biotechnology (BIO) | - | - | 46,2 md | 54,01 md | 64,16 md | |||||
Gross Profit | - | - | 16,78 md | 20,66 md | 25,72 md | |||||
Operating Income | - | - | −20,68 md | −17,83 md | −13,28 md | |||||
Pharmaceutical Product Distribution | ||||||||||
Other | 7,15 md | 9,72 md | 70,87 md | 24,98 md | 25,58 md | |||||
Total Assets | 4,1 md | 22,72 md | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
CAPEX | −262 mn | −310 mn | - | - | - | |||||
Gross Profit | 804 mn | 633 mn | 7,65 md | 5,43 md | 5,22 md | |||||
D&A | 199 mn | 224 mn | - | - | - | |||||
Operating Income | 386 mn | 144 mn | −684 mn | 1,03 md | 647 mn | |||||
Wholesale and Retail | 134 md | 155 md | - | - | - | |||||
Total Assets | 71,38 md | 85,88 md | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
CAPEX | −595 mn | −104 mn | - | - | - | |||||
Gross Profit | 10,25 md | 12,36 md | - | - | - | |||||
D&A | 1,29 md | 1,37 md | - | - | - | |||||
Operating Income | 465 mn | −49 mn | - | - | - | |||||
Eliminations | −15,79 md | −17,88 md | −13,16 md | −12,24 md | −10,58 md | |||||
Total Assets | −150 md | −180 md | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
CAPEX | 20 mn | - | - | - | - | |||||
Gross Profit | −47 mn | 19 mn | −324 mn | −515 mn | 830 mn | |||||
D&A | - | - | - | - | - | |||||
Operating Income | −66 mn | 1,38 md | −324 mn | −515 mn | 830 mn |
Historik över geografisk fördelning av omsättning
| Skatteperiod: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Europe | 263 md | 328 md | 501 md | 511 md | 551 md | |||||
Total Assets | 156 md | 199 md | 1 320 md | 1 557 md | 1 656 md | |||||
CAPEX | −11,49 md | −18,37 md | −94,08 md | −63,06 md | −65,43 md | |||||
North America | - | - | 221 md | 255 md | 276 md | |||||
Total Assets | - | - | 3,09 md | 953 mn | 975 mn | |||||
CAPEX | - | - | - | −1 mn | - | |||||
APAC | - | - | 43,07 md | 48,62 md | 54,71 md | |||||
Total Assets | - | - | 14,62 md | 18,73 md | 15,74 md | |||||
CAPEX | - | - | −344 mn | −436 mn | −890 mn | |||||
Latin America | 17,6 md | 27,88 md | 31,68 md | 35,53 md | 38,31 md | |||||
Total Assets | 10,21 md | 20,16 md | 23,14 md | 26,23 md | 25,03 md | |||||
CAPEX | −235 mn | −284 mn | −215 mn | −222 mn | −82 mn | |||||
Rest of The World | 31,24 md | 36,5 md | 8,26 md | 6,71 md | 9,05 md | |||||
Total Assets | 14,58 md | 15,6 md | - | - | - | |||||
CAPEX | −460 mn | −300 mn | - | - | - | |||||
EU 12 (Excluding Poland and Romania) | - | - | - | - | - | |||||
China | 15,59 md | 21,71 md | - | - | - | |||||
Total Assets | 1,99 md | 5,06 md | - | - | - | |||||
Other CIS Republics | - | - | - | - | - | |||||
Ukraine | - | - | - | - | - | |||||
Russia | - | - | - | - | - | |||||
WEU | - | - | - | - | - | |||||
Poland | - | - | - | - | - | |||||
Romania | - | - | - | - | - | |||||
Hungary | 44,38 md | 46,62 md | - | - | - | |||||
Total Assets | 888 md | 996 md | - | - | - | |||||
CAPEX | −127 md | −52,07 md | - | - | - | |||||
CIS (Commonwealth of Independent States) | 135 md | 180 md | - | - | - | |||||
Total Assets | 70,48 md | 102 md | - | - | - | |||||
CAPEX | −3,96 md | −552 mn | - | - | - | |||||
United States of America | 123 md | 162 md | - | - | - | |||||
Total Assets | 4,15 md | 2,86 md | - | - | - | |||||
CAPEX | - | - | - | - | - |
- Börsen
- Aktier
- RICHTER Aktie
- CHWGR Aktie
- Finanser Gedeon Richter
- Affärssegment
Välj din utgåva
All finansiell information anpassad till den nationella nivån
















